Europe — EMA
Kamiren Xl (Doxazosin)
GNH USA supplies Kamiren Xl (Doxazosin), an alpha-1 adrenergic blocker for hypertension and benign prostatic hyperplasia. Request a quote for global supply.
Request sourcing
What is Doxazosin?
Doxazosin, the active ingredient in Kamiren Xl, is a alpha-1 adrenergic blocker presented as a oral tablet for oral use. It treats hypertension and benign prostatic hyperplasia in adult patients.
GNH USA supplies Kamiren Xl as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Doxazosin used for?
Doxazosin is indicated for conditions that involve the alpha‑1 adrenergic pathway.
- Hypertension: lowers blood pressure by reducing peripheral vascular resistance. - Benign prostatic hyperplasia (BPH): eases urinary symptoms by relaxing smooth muscle in the prostate and bladder neck.
What are the side effects of Doxazosin?
Adverse reactions may vary in frequency and severity.
Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Nasal congestion - Peripheral edema - Orthostatic hypotension
Serious or Rare Side Effects: - Severe hypotension or syncope - Priapism - Hepatic dysfunction - Acute renal failure - Allergic reactions such as rash or angioedema
What precautions apply to Doxazosin?
Before initiating therapy, consider the following safety measures.
- Blood pressure monitoring: check regularly to avoid excessive hypotension. - Renal function assessment: adjust use in patients with impaired clearance. - Hepatic impairment: use with caution in moderate to severe liver disease. - Concomitant antihypertensives: evaluate risk of additive blood‑pressure lowering effects. - Sudden discontinuation: taper gradually to prevent rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.
What does Doxazosin interact with?
Doxazosin may interact with other medicines; some require avoidance, others close monitoring.
Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil) – risk of profound hypotension. - Potent CYP3A4 inhibitors (e.g., ketoconazole) – may increase plasma levels. - Other alpha‑blockers – additive vasodilatory effect.
Moderate Interactions (Monitor Closely):\n- Diuretics – may enhance orthostatic hypotension. - ACE inhibitors or ARBs – combined effect on blood pressure. - Beta‑blockers – monitor for excessive heart‑rate reduction. - NSAIDs – may blunt antihypertensive response. - Antidepressants with serotonergic activity – observe for dizziness.
